Sarepta Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Momentum Movers Trader Talk

Leerink Partners Upgrades Sarepta Therapeutic (SRPT) to Market PerformSeptember 19, 2016 1:29 PM Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen ApprovalSeptember 19, 2016 1:08 PM Sarepta Therapeutics (SRPT) Pushes to Highs Following FDA Approval; +90%September 19, 2016 11:21 AM Sarepta Therapeutics (SRPT) Shares Resume Trading; Now Up 82% on FDA Eteplirsen ApprovalSeptember 19, 2016 9:59 AM